SearchDictionaryMobileLogin

C Bokemeyer Selected Research

Drug Therapy (Chemotherapy)

09/2008Pharmacotherapy of relapsed metastatic testicular cancer.
08/2008Cerebral metastases in non-seminomatous germ cell tumour patients undergoing primary high-dose chemotherapy.
12/2007Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine.
04/2005Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
12/2004[Chemotherapy for germ cell cancer]
12/2004Chemotherapy in elderly patients with advanced lung cancer. Part II: Treatment of non-small cell lung cancer (NSCLC).
10/2004Chemotherapy in elderly patients with advanced lung cancer. Part I: General aspects and treatment of small cell lung cancer (SCLC).
09/2004Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
04/2004The role of high-dose chemotherapy in relapsed germ cell tumors.
01/2004[Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker]
12/2003[Chemotherapy of advanced colorectal carcinoma: treatment options for elderly patients]
11/2003Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
09/2003Current aspects of high-dose chemotherapy in germ-cell tumors.
06/2003Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors.
04/2003Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support.
11/2002Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer.
04/2002Capecitabine in patients with breast cancer relapsing after high-dose chemotherapy plus autologous peripheral stem cell transplantation--a phase II study.
02/2002Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET.
06/2001Clinical impact of germ cell tumor cells in apheresis products of patients receiving high-dose chemotherapy.
05/2001Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.
04/2001Chemotherapy in elderly patients with colorectal cancer.
04/2001Salvage chemotherapy in relapsed germ cell tumors.
04/2001Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy.
03/2001Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
02/2001[Chemotherapy of colorectal cancer--which therapy is justified for elderly patients?]
09/2000[Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas]
05/2000First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases.
03/2000Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma.
01/2000The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors.

Articles by Research Topic

Disease

24Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
03/2008 - 05/2000
8Testicular Neoplasms (Testicular Cancer)
09/2008 - 09/2000
8Neoplasms (Cancer)
01/2007 - 01/2000
6Colorectal Neoplasms (Colorectal Cancer)
05/2008 - 02/2001
4Gastrointestinal Neoplasms (Gastrointestinal Cancer)
08/2005 - 10/2003
3Breast Neoplasms (Breast Cancer)
09/2008 - 04/2002
2Neoplasm Metastasis (Metastasis)
08/2008 - 05/2000
2Adenocarcinoma
09/2006 - 03/2000
2Sarcoma (Soft Tissue Sarcoma)
05/2006 - 03/2003
2Stomach Neoplasms (Stomach Cancer)
08/2005 - 06/2002
2Lung Neoplasms (Lung Cancer)
12/2004 - 10/2004
1Multiple Myeloma
06/2008
1Small Cell Carcinoma
06/2006
1Leukemia
04/2005
1Residual Neoplasm
09/2004
1Seminoma
08/2004
1Prostatic Neoplasms (Prostate Cancer)
09/2001
1Carcinoma (Carcinomatosis)
09/2000

Drug/Important Bio-Agent (IBA)

12Cisplatin (Platino)FDA LinkGeneric
03/2008 - 01/2000
8Leucovorin (Folinic Acid)FDA LinkGeneric
05/2008 - 10/2000
7Paclitaxel (Taxol)FDA LinkGeneric
03/2008 - 10/2000
6Fluorouracil (Carac)FDA LinkGeneric
05/2008 - 06/2002
4IfosfamideFDA LinkGeneric
11/2003 - 01/2000
3capecitabine (Xeloda)FDA Link
05/2008 - 04/2002
3irinotecan (Camptosar)FDA LinkGeneric
05/2008 - 09/2002
3gemcitabineFDA Link
03/2008 - 01/2004
3oxaliplatin (Eloxatin)FDA Link
03/2008 - 04/2002
3Mitomycin (Mitomycin-C)FDA LinkGeneric
08/2004 - 03/2000
2bendamustineFDA Link
12/2007 - 08/2000
2Proteins (Proteins, Gene)IBA
01/2007 - 10/2004
2Epidermal Growth Factor Receptor (EGF Receptor)IBA
06/2006 - 07/2002
2Carboplatin (JM8)FDA LinkGeneric
08/2004 - 01/2001
2Etoposide (VP 16)FDA LinkGeneric
11/2003 - 01/2001
2Amifostine (Ethyol)FDA LinkGeneric
08/2000 - 01/2000
1Chemokine CXCL13IBA
09/2008
1celecoxib (Celebrex)FDA Link
05/2008
1taxaneIBA
09/2006
1ixabepilone (BMS 247550)FDA Link
09/2006
1matuzumabIBA
06/2006
1CAV protocol (CHO)FDA Link
08/2005
1trofosfamideIBA
03/2003
1UracilIBA
05/2002
1TegafurIBA
05/2002
1SERPIN-B5 (maspin)IBA
09/2001
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
01/2001

Therapy/Procedure

29Drug Therapy (Chemotherapy)
09/2008 - 01/2000
4Combination Drug Therapy (Combination Chemotherapy)
03/2008 - 08/2000
2Aftercare (After-Treatment)
04/2004 - 09/2000
1Hematopoietic Stem Cell Transplantation
06/2008
1Adrenalectomy
04/2002
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
04/2002
1Blood Component Removal (Apheresis)
06/2001